Cargando…
Autophagy-deficient breast cancer shows early tumor recurrence and escape from dormancy
Breast cancer patients who initially respond to cancer therapies often succumb to distant recurrence of the disease. It is not clear why people with the same type of breast cancer respond to treatments differently; some escape from dormancy and relapse earlier than others. In addition, some tumor cl...
Autores principales: | Aqbi, Hussein F., Tyutyunyk-Massey, Liliya, Keim, Rebecca C., Butler, Savannah E., Thekkudan, Theresa, Joshi, Supriya, Smith, Timothy M., Bandyopadhyay, Dipankar, Idowu, Michael O., Bear, Harry D., Payne, Kyle K., Gewirtz, David A., Manjili, Masoud H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955162/ https://www.ncbi.nlm.nih.gov/pubmed/29774126 http://dx.doi.org/10.18632/oncotarget.25197 |
Ejemplares similares
-
Gr1(−/low)CD11b(−/low)MHCII(+) myeloid cells boost T cell anti‐tumor efficacy
por: Payne, Kyle K., et al.
Publicado: (2018) -
Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets
por: Aqbi, Hussein F., et al.
Publicado: (2020) -
The premise of personalized immunotherapy for cancer dormancy: Cancer dormancy vaccines
por: Manjili, Masoud H.
Publicado: (2020) -
Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure
por: Kmieciak, Maciej, et al.
Publicado: (2011) -
Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma
por: Mirshahi, Faridoddin, et al.
Publicado: (2022)